Michael Bruce
Chief Executive Officer at Exo Therapeutics, Inc.
Michael Bruce active positions
Companies | Position | Start | End |
---|---|---|---|
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Chief Executive Officer | 2020-01-31 | - |
Career history of Michael Bruce
Former positions of Michael Bruce
Companies | Position | Start | End |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 2017-09-30 | 2020-01-31 |
CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 2014-12-31 | 2016-12-31 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 2002-12-31 | 2014-12-31 |
PFIZER, INC. | Corporate Officer/Principal | 2002-12-31 | 2014-12-31 |
Training of Michael Bruce
Williams College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistics
International
United States | 7 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
KALEIDO BIOSCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private companies | 2 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Michael Bruce
- Experience